Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label, Multicenter Study for Evaluation of Safety and Efficacy of Artemether-Lumefantrine Tablets (6-Dose Regimen) in African Infants and Children in the Treatment of Acute Uncomplicated Falciparum Malaria

NCT00709969 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT00709969
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00709969 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label, Multicenter Study for Evaluation of Safety and Efficacy of Artemether-Lumefantrine Tablets (6-Dose Regimen) in African Infants and Children in the Treatment of Acute Uncomplicated Falciparum Malaria
Lead sponsor
Novartis
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2002
Completion date
February 28, 2003
Enrollment
310 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

plasmodium falciparum malaria